ANEB: מחיר למכירות Anebulo Pharmaceuticals Inc

Anebulo Pharmaceuticals (ANEB) develops cannabinoid antidotes through partnerships with medical centers. The high margins of proprietary products within this niche are confirmed by the price/sales ratio, which remains around . Outsourcing primary testing to external laboratories while maintaining full control over intellectual property minimizes operational risks, ensuring steady growth in business value.

The P/S ratio serves as a key filter when assessing fair value and stress-testing overpayment risks. This metric compares market capitalization to annual revenue, reflecting investor expectations regarding future cash flows. By analyzing historical P/S levels, one can evaluate the extent of an asset's overvaluation. For Anebulo Pharmaceuticals (ANEB), this indicator demonstrates the market's bet on the successful integration of a unique antidote into the emergency medicine system.